Efficacy Results of a 52-week Trial of Adalimumab in the Treatment of Refractory Sarcoidosis.Nadera Sweiss, Robert P. Baughman, Edward T. Naureckas et al.|PubMed|2014Cited by 120
52-Week Trial Results Of Adalimumab As Novel Therapy For Refractory, Progressive Pulmonary SarcoidosisNadera Sweiss, Michael H. Ellman, Imre Noth et al.|Unknown|2010Cited by 2